Colgate Palmolive (CL) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Colgate Palmolive (CL)

90.08

-1.55 (1.69%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

30 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Colgate Palmolive (CL) is facing a challenging year, particularly in the consumer staples sector. However, the company has recently demonstrated resilience by beating both top and bottom line expectations, suggesting a recovery in its performance. Additionally, improvements in its supply chain may further support its growth prospects. While the company is dealing with tariff costs that were originally projected at $200 million but have now reduced to $75 million, this represents a positive development. Investors are encouraged to consider buying the stock at its 52-week lows, especially with a dividend yield of approximately 2.5%, indicating potential for steady returns.

Consensus

Buy

Valuation

Fair Value

Similar

BUY

Buy it now at 52-week lows and ride the 2.5% dividend.

BUY

It's been a rough year for staples. CL beat top and bottom line and their supply chain is improving, but they have potentially $200 million in costs from tariffs, but reduced to $75 million. He continues to like it.

DON'T BUY

It has amazing pet food and toothpaste businesses, but pays only a 2.37% dividend yield, far below current bond yields. Could go even lower.

Premium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

Every day, millions of consumers around the world trust our products to care for themselves and the ones they love. colgate-palmolive is a global company serving people in over 200 countries and territories with consumer products that make their lives healthier and more enjoyable. colgate manufactures and markets oral care, personal care, home care and pet nutrition products under such internationally recognized brand names as colgate, palmolive, speed stick, lady speed stick, softsoap, irish spring, protex, sorriso, kolynos, elmex, tom’s of maine, sanex, ajax, axion, fabuloso, soupline and suavitel, as well as hill’s science diet, hill’s prescription diet and hill’s ideal balance. Social media mentions are up 267% in the past 24h.

BUY

options They bought 3,000 October calls at the $80 strike with shares trading at $77.50. He bought and will upside calls against them as it rallies.

WEAK BUY

Struggling today after earnings. Organic sales did surprise, up 10%, while Latin American growth was over 12%. But multinationals with lots of overseas exposure will struggle against the high USD.

BUY

He saw some upside buying today in options and almost in positive territory on a tough day like today.

DON'T BUY

Wall Street is circumspect about it, considering it a stay at home stock. As a battleground stocks now, avoid.

Wealthica Track your Stocks in your Watch List

BUY ON WEAKNESS

Global consumer products that dominates in oral personal care products. They have grown well in the past in emerging markets, but this space is quite competitive. The stock has always traded at high multiples, which has kept her out of this stock and continues to do so.

DON'T BUY

The problem is that following a multi-decade interest rate decline, a rise in interest rates going forward will impact this as it is viewed as a bond proxy. It is an interest rate issue. This is not the time to step in right now.

SELL

He is avoiding staples right now. They are trading very, very rich. This company has had a negative earnings revision and are really struggling in some of their core categories with pricing pressures and volume. Not a lot of positive things to say about this. He would be moving on to a different sector, on the view that we will be seeing higher rates. This is not a “Growth” story, it is a “how do we save the ship” story.

HOLD

Bristol-Myers (BMY-N) or Colgate (CL-N)? These are both very good companies and you are probably getting decent yields on both. The dividend growth is not high enough to be in his funds. Dividend yield of 2.2%.

HOLD

Probably one of the better staple companies. In July it had a big Venezuelan devaluation which resulted in a sharp drop in earnings. This was followed by the currency earnings drag. You are going to probably see some pullbacks and corrections in valuations, but longer-term this is a very good story if you have a multi-year view on the company.

WEAK BUY

A consumer brand business. The issue is that 80% of revenue is from outside of North America. 21 times earnings and a good dividend yield. Another issue is that they have good brand loyalty but they are known for their toothpaste. He would prefer they sold off Hills, the veterinary business. This company performs well over the long term so if you have a long time horizon then buy on a pull back. They increase dividends regularly.

BUY

It is a company that makes things you need to buy. Compared to UL-N they have been held back. People have been wanting to stick to domestic markets. Prefers this one.

Showing 1 to 15 of 51 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Colgate Palmolive (CL) Frequently Asked Questions

What is Colgate Palmolive stock symbol?

Colgate Palmolive is a American stock, trading under the symbol CL (previously CL-N on Stockchase) on the New York Stock Exchange (CL). It is usually referred to as NYSE:CL or CL

Is Colgate Palmolive a buy or a sell?

In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on CL (previously CL-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Colgate Palmolive.

Is Colgate Palmolive a good investment or a top pick?

Colgate Palmolive was recommended as a Top Pick by Jim Cramer - Mad Money on 2025-09-10. Read the latest stock experts ratings for Colgate Palmolive.

Why is Colgate Palmolive stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Colgate Palmolive.

Is Colgate Palmolive worth watching?

Colgate Palmolive is followed by 30 investors on Stockchase and is a trending stock that is worth watching.

What is Colgate Palmolive stock price?

On 2026-07-23, Colgate Palmolive (CL) stock closed at a price of $90.08.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Colgate Palmolive (CL)